About Bambusa Therapeutics
Bambusa Therapeutics is a private company based in Boston, Massachusetts, incorporated in 2024 in Delaware. It has reported $67,367,912 raised in three offerings on Form D since January 2025.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 12, 2025 | Feb 26, 2025 | $53,267,941of $88.8M target | 16 | $3.3M | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2024 | Jan 8, 2025 | $8,999,974fully sold | 9 | $999K | EquityRule 506(b) | Form D ↗ |
| Jun 12, 2024 | Jan 8, 2025 | $5,099,997fully sold | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $67,367,912 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bambusa Therapeutics's Form D filed Feb 26, 2025.
SM
Sean Marett
Director
HJ
Helmut Jeggle
Director
DD
Derek DiRocco
Director
SX
Shanshan Xu
Executive officer, director and promoter